Seiji Nagashima   Hiroshi Soda   Mikio Oka   Takeshi Kitazaki   Ken Shiozawa   Yoichi Nakamura   Masaaki Takemura   Hikaru Yabuuchi   Minoru Fukuda   Kazuhiro Tsukamoto   Shigeru Kohno   
Cancer chemotherapy and pharmacology 58(5) 594-600 2006年11月 [査読有り]
PURPOSE: Breast cancer resistance protein (BCRP) confers resistance against topoisomerase I inhibitors in cancer cells. Very recently, we reported that gefitinib reverses BCRP-mediated drug resistance by direct inhibition. However, it remains unde...